Stock research.
Every claim sourced.
Evidence-based equity research for retail investors. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every number traces to a primary source.
No credit card. Cancel anytime.
Valuation elevated (forward P/E 38.2 vs sector 24.1) offsets strong revenue growth (122% YoY per latest 10-Q). With Fed funds at 5.33% and the 10Y at 4.38%, risk-asset multiples face compression. Wait for entry below $420 or for next earnings print.
Read-only sync via Plaid + SnapTrade. We never execute trades.
Claude, GPT, Gemini — each lens runs on a different vendor so no single blind spot becomes yours.
Every number traces back to its 10-Q, FRED series, or market feed. A supervisor rejects unverifiable claims.
Every brief is scored at 7d / 30d / 90d / 365d. The public track record shows hits and misses both.
Most investing tools give you opinions.
ClearPath gives you evidence.
A research desk for your portfolio.
Ingest
Pull live data from 12+ authoritative sources — SEC filings, Fed indicators, real prices. Nothing cached, nothing summarized.
Analyze
Three investment lenses — Quality, Momentum, Context — examine the same evidence in parallel. Each lens applies its own discipline; disagreement between them is surfaced, not hidden.
Verify
A supervisor cross-checks every claim against the source data. Unverifiable claims are flagged and stripped.
Deliver
A clear recommendation — BUY, HOLD, or SELL — with every supporting number traceable to its source.
We read the filings.
We verify the numbers.
Every recommendation references primary sources. No black-box AI training data. No hedge-fund hearsay.
The honest comparison.
- ✗Answers pulled from stale training data
- ✗Single model, confident opinion
- ✗No citations, no traceability
- ✗Overfit to bull markets
- ✗Can’t tell you when it doesn’t know
- Live data from 12+ authoritative sources
- Three investment lenses — Quality, Momentum, Context — cross-examine the same evidence
- Every number traces to a primary source
- Bias toward HOLD when evidence is ambiguous
- Tells you exactly what it needs to be more confident
Ready for
considered decisions?
Start your free 30-day trial — full access, no credit card. Built for investors who want evidence, not vibes.
No credit card. Cancel anytime.